Early Kidney Damage Markers after Deferasirox Treatment in Patients with Thalassemia Major: A Case-Control Study

BACKGROUND: The life of patients with β-thalassemia major depends on blood transfusion. Regular blood transfusion leads to hemosiderosis in their main organs. The aim of this study was to compare the effects of deferasirox and deferoxamine on renal damage in patients with β-thalassemia major. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Badeli, Hamidreza, Baghersalimi, Adel, Eslami, Sajjad, Saadat, Farshid, Rad, Afagh Hassanzadeh, Basavand, Rokhsar, Papkiadeh, Soghra Rafiei, Darbandi, Bahram, Kooti, Wesam, Peluso, Ilaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501149/
https://www.ncbi.nlm.nih.gov/pubmed/31178966
http://dx.doi.org/10.1155/2019/5461617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501149/
https://www.ncbi.nlm.nih.gov/pubmed/31178966
http://dx.doi.org/10.1155/2019/5461617

Ejemplares similares